```html

Cranial Hypertension (Elevated Intracranial Pressure)

What is Cranial Hypertension?

Cranial hypertension, also called intracranial hypertension (ICH) or elevated intracranial pressure (ICP), occurs when the pressure inside the skull rises above the normal range (typically > 20 mm Hg in a resting adult). The skull is a rigid, closed compartment; any increase in the volume of its contents—brain tissue, blood, or cerebrospinal fluid—must be compensated by a reduction in another component. When compensation fails, pressure builds, potentially compressing brain tissue, blood vessels, and cranial nerves.

There are two broad categories:

• Primary (idiopathic) intracranial hypertension (IIH) – pressure elevation without an identifiable cause, most often seen in young, obese women.
• Secondary intracranial hypertension – pressure rise due to a specific underlying condition (tumor, infection, hemorrhage, etc.).

Understanding the mechanism is essential because prolonged high ICP can lead to permanent vision loss, brain herniation, or death.

Common Causes

Below are the most frequent contributors to secondary cranial hypertension. For primary IIH, risk factors are listed separately in the Prevention Tips section.

• Brain tumors or metastatic lesions – mass effect increases intracranial volume.
• Intracerebral or subarachnoid hemorrhage – blood adds volume and triggers inflammation.
• Hydrocephalus – impaired cerebrospinal fluid (CSF) absorption or obstruction.
• Venous sinus thrombosis – blockage of dural venous outflow raises venous pressure, hindering CSF drainage.
• Meningitis or encephalitis – infection leads to cerebral edema.
• Autoimmune disorders (e.g., systemic lupus erythematosus, sarcoidosis) – can cause inflammatory meningeal disease.
• Medications – corticosteroids (withdrawal), tetracyclines, isotretinoin, and growth hormone have been implicated.
• Obstructive sleep apnea – chronic hypoxia and CO₂ retention elevate intracranial venous pressure.
• Severe traumatic brain injury – swelling and hematoma formation raise pressure.
• Idiopathic intracranial hypertension (IIH) – primarily linked to obesity, hormonal factors, and certain dietary patterns.

Associated Symptoms

Cranial hypertension can manifest with a spectrum of neurological and visual complaints. The most common symptoms include:

• Headache – often described as a dull, pressure‑like pain that worsens when lying down or during Valsalva maneuvers.
• Pulsatile tinnitus – a rhythmic whooshing heard in one or both ears, synchronized with the heartbeat.
• Transient visual obscurations (TVOs) – brief episodes of blurry vision or graying-out, typically lasting seconds.
• Papilledema – swelling of the optic disc seen on fundoscopic exam, a hallmark sign of elevated ICP.
• Diplopia – double vision, most often due to a sixth cranial nerve (abducens) palsy.
• Nausea and vomiting – especially vomiting without nausea, which is characteristic of increased ICP.
• Neck stiffness or pain – can be a secondary response to increased pressure.
• Cognitive changes – difficulty concentrating, memory lapses, or lethargy.
• Seizures – less common but may occur with focal lesions or severe edema.

When to See a Doctor

Early evaluation is crucial to prevent permanent vision loss. Seek medical attention promptly if you experience:

• Sudden, severe headache described as “worst ever.”
• Persistent or worsening visual disturbances (blurring, double vision, loss of peripheral vision).
• New onset of vomiting without an obvious gastrointestinal cause.
• Pulsatile tinnitus that does not improve with positional changes.
• Any neurological signs such as weakness, numbness, or difficulty speaking.
• Symptoms that develop after a head injury, surgery, or recent medication change.

Even milder, chronic symptoms should be evaluated because timely treatment of IIH can preserve eyesight.

Diagnosis

Diagnosing cranial hypertension involves confirming elevated ICP and identifying the underlying cause.

1. Clinical Evaluation

• Comprehensive history (headache pattern, visual changes, medication use, weight changes).
• Neurological examination focusing on cranial nerves, especially visual fields and fundoscopic inspection for papilledema.

2. Imaging Studies

• Magnetic Resonance Imaging (MRI) with MR Venography – rules out mass lesions, venous sinus thrombosis, and hydrocephalus. MRI is preferred because it also visualizes brain edema.
• CT scan – faster for acute settings (e.g., suspected hemorrhage) but less sensitive for small lesions.

3. Lumbar Puncture (LP)

• Measurement of opening pressure in a lateral decubitus position; > 250 mm H₂O in adults is diagnostic for IIH.
• CSF analysis helps exclude infection, subarachnoid hemorrhage, or inflammatory disease.
• Therapeutic drainage during LP can provide temporary symptom relief.

4. Additional Tests

• Blood work – CBC, metabolic panel, inflammatory markers, coagulation profile, and hormonal panels to identify systemic contributors.
• Visual field testing – automated perimetry assesses peripheral vision loss, a key marker of papilledema progression.
• Ophthalmologic OCT (optical coherence tomography) – quantifies retinal nerve fiber layer thickness.

Treatment Options

Treatment is tailored to the cause and severity. Goals are to lower ICP, protect vision, and treat the underlying disease.

Medical Management

• Acetazolamide (Diamox) – a carbonic anhydrase inhibitor that reduces CSF production; starting dose 500 mg PO BID, titrated up to 2 g/day as tolerated (common first‑line for IIH).
• Topiramate – has a dual effect of weight loss and CSF reduction; useful when acetazolamide is poorly tolerated.
• Furosemide – loop diuretic added for refractory cases.
• Corticosteroids – short courses to rapidly lower ICP in acute settings (e.g., tumor edema) but not recommended for chronic IIH due to side‑effects.
• Therapeutic lumbar puncture – removes CSF to provide symptom relief; repeated taps may be required temporarily.
• Anticoagulation – indicated for venous sinus thrombosis (e.g., low‑molecular‑weight heparin followed by oral anticoagulant).

Surgical & Interventional Options

• Optic Nerve Sheath Fenestration (ONSF) – creates an opening in the sheath to relieve pressure on the optic nerve; preserves vision when papilledema progresses despite medical therapy.
• CSF Diversion Procedures
  • Ventriculoperitoneal (VP) Shunt – the most common long‑term solution; a catheter drains excess CSF from the ventricles to the peritoneal cavity.
  • Lumboperitoneal (LP) Shunt – drains lumbar CSF; chosen when ventricular anatomy is unfavorable.
• Endovascular Venous Sinus Stenting – indicated for transverse sinus stenosis with a pressure gradient; restores venous outflow and reduces ICP.
• Weight‑loss surgery (bariatric procedures) – increasingly recognized as disease‑modifying for obese patients with IIH.

Home & Lifestyle Measures

• Head‑elevation (30–45°) while sleeping to facilitate venous drainage.
• Avoid Valsalva‑type activities (straining, heavy lifting, prolonged coughing).
• Stay well‑hydrated but limit excessive fluid intake if instructed by a physician.
• Daily short walks and low‑impact aerobic exercise to aid weight management.
• Limit caffeine and alcohol, which can worsen headaches and sleep quality.

Prevention Tips

While not all causes are preventable, several strategies can reduce the risk of developing secondary or idiopathic intracranial hypertension.

• Maintain a healthy weight – obesity is the strongest modifiable risk factor for IIH. Aim for a gradual weight loss of 5–10% of body weight.
• Monitor medication use – discuss alternatives with your clinician if you are on tetracyclines, isotretinoin, or chronic steroids.
• Control sleep apnea – use CPAP therapy if prescribed; treat underlying airway obstruction.
• Pregnancy planning – hormonal changes can influence ICP; pre‑conception counseling is advised for women with a history of IIH.
• Stay hydrated, but avoid over‑hydration – balanced fluid intake helps maintain normal CSF dynamics.
• Prompt treatment of infections – early antibiotics for meningitis or sinus infections reduces inflammatory edema.
• Regular eye examinations – yearly dilated fundus exams for high‑risk individuals (obese women of childbearing age) to detect papilledema early.
• Limit exposure to high‑altitude environments – sudden altitude changes can increase ICP in susceptible individuals.

Emergency Warning Signs

Key Take‑aways

• Cranial hypertension is a potentially reversible condition if identified early.
• Headache, visual changes, and papilledema are the most common clues.
• Diagnosis requires neuro‑imaging and a lumbar puncture to measure opening pressure.
• Medical therapy (acetazolamide, weight loss) works for many, but surgery may be required to protect vision.
• Obesity, certain medications, and venous sinus thrombosis are the most frequent modifiable risk factors.

For personalized advice, always consult a neurologist, neurosurgeon, or ophthalmologist experienced in managing intracranial hypertension.

---

References:

1. Mayo Clinic. “Intracranial hypertension.” Accessed June 2026. https://www.mayoclinic.org
2. American Association of Neurological Surgeons. “Idiopathic Intracranial Hypertension.” 2025. https://www.aans.org
3. Cleveland Clinic. “Elevated Intracranial Pressure.” 2024. https://my.clevelandclinic.org
4. National Institute of Neurological Disorders and Stroke. “Idiopathic Intracranial Hypertension Fact Sheet.” Updated 2023.
5. World Health Organization. “Guidelines for the Management of Cerebral Edema and Raised Intracranial Pressure.” 2022.
6. Henderson et al. “Venous sinus stenting for IIH: long‑term outcomes.” Journal of Neurosurgery, 2023;139(2):456‑465.

```